Increased coronary atherosclerosis and immune activation in HIV-1 elite controllers-Reference-Cited by-同舟云学术

Increased coronary atherosclerosis and immune activation in HIV-1 elite controllers

Published:2012-11-28 Issue:18 Volume:26 Page:2409-2412
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

Pereyra Florencia,Lo Janet,Triant Virginia A.,Wei Jeffrey,Buzon Maria J.,Fitch Kathleen V.,Hwang Janice,Campbell Jennifer H.,Burdo Tricia H.,Williams Kenneth C.,Abbara Suhny,Grinspoon Steven K.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference20 articles.

1. Soluble CD163, a novel marker of activated macrophages, is elevated and associated with noncalcified coronary plaque in HIV-infected patients.;Burdo;J Infect Dis,2011

2. T cell activation and senescence predict subclinical carotid artery disease in HIV-infected women.;Kaplan;J Infect Dis,2011

3. Persistent low-level viremia in HIV-1 elite controllers and relationship to immunologic parameters.;Pereyra;J Infect Dis,2009

4. Evidence for persistent low-level viremia in individuals who control human immunodeficiency virus in the absence of antiretroviral therapy.;Hatano;J Virol,2009

5. Relationship between T cell activation and CD4 T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy.;Hunt;J Infect Dis,2008

Cited by 178 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Galectin-3, Galectin-9, and Interleukin-18 Are Associated with Monocyte/Macrophage Activation and Turnover More so than Simian Immunodeficiency Virus-Associated Cardiac Pathology or Encephalitis;AIDS Research and Human Retroviruses;2024-09-01

2. Sustained aviremia despite anti-retroviral therapy non-adherence in male children after in utero HIV transmission;Nature Medicine;2024-06-06

3. HIV-Associated Hypertension: Risks, Mechanisms, and Knowledge Gaps;Circulation Research;2024-05-24

4. Inflammation in HIV and Its Impact on Atherosclerotic Cardiovascular Disease;Circulation Research;2024-05-24

5. Pregnancy Management in HIV Viral Controllers: Twenty Years of Experience;Pathogens;2024-04-10